SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9820Value: Using the Cowen model, DCF on sum of parts is about $24. Some highlightRobohogs-7/30/2008
9819Considering they issued shares near lows a few years ago, I am surprised they diRobohogs-7/30/2008
9818They announced plans to sell or float drug delivery, so no need to dilute.rkrw-7/30/2008
9817A surprising degree of market efficiency: WYE -12%, a market-cap loss of $7B ELDewDiligence_on_SI-7/30/2008
9816ELN seems to crash once every three years for one reason or another. I'm surQualified Opinion-7/30/2008
9815Goldman Sachs is one of the positive firms out on Elan (NYSE:ELN) this morning aclutterer-7/30/2008
9814Elan (NYSE:ELN): After selling for the wrong reasons, now is the time to buy forclutterer-7/30/2008
9813KM maybe familiar with subprime considering his previous employment. <g> Qualified Opinion-7/30/2008
9812You forgot to say it was a cute sound bite from a gloating short seller who is prkrw-7/30/2008
9811<i>"giant market, giant gamble". I see it as bold, not stupid.&lDewDiligence_on_SI-7/30/2008
9810Just caught up with all the comments since my last post. They are much appreciatfred hayes-7/30/2008
9809My soundbite on your soundbite -g- Sanofi Aventis sure did a lot of spending onBiotech Jim-7/30/2008
9808My soundbite on the Bap situation, FWIW: <i> “Never before, in the historDewDiligence_on_SI-7/30/2008
9807Any significant sell off on a new PML case would represent a wonderful buying opbiofisher-7/30/2008
9806Thanks Tuck and for those links. Thanks Jim for your thoughts on this.. I forgotzeta1961-7/30/2008
9805>Comments?< FWIW, I don't see anyway the drug will work for ApoE4(+) idos-7/30/2008
9804Texas, I agree the drug is DOA. I suspect the stock will continue to fall as thMichael Young-7/30/2008
9803Buying WYE through shorting 35/37.5 OCT puts probably the best value of the two Robohogs-7/30/2008
9802According to Lowe, the significance of the APOE4 mutation in AD was identified itom pope-7/30/2008
98016 of 12 were re-dosed. All except 2 of 12 were on high doses. This is overblowRobohogs-7/30/2008
9800Take 7-8x as blockbusters get more value than non. On current sales of 1 B, thaRobohogs-7/30/2008
9799Well, last evening when I knew the news from ICAD was coming out, I decided to gBiotech Jim-7/30/2008
9798>>! And since this trial doesn’t seem to have been designed from the startuck-7/30/2008
9797! <i>And since this trial doesn’t seem to have been designed from the statom pope-7/30/2008
9796I agree, the TauRx CEO is a bit more conflicted than most, and if the purified ftuck-7/30/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News